Company Filing History:
Years Active: 2016
Title: Klaus Christensen: Innovator in Neural Stem Cell Research
Introduction
Klaus Christensen is a notable inventor based in Oberwil BL, Switzerland. He has made significant contributions to the field of cellular biology, particularly in the conversion of somatic cells to neural stem cells.
Latest Patents
Christensen holds a patent for the "Conversion of somatic cells to induced reprogrammed neural stem cells (irNSCs)." This application details a method for converting somatic cells into Neural Stem Cells (NSCs). It specifically addresses the conversion of human fibroblasts, keratinocytes, or adipocytes into neural stem cells through a series of gene transduction steps and the use of a chemically defined medium for induction. He has 1 patent to his name.
Career Highlights
Throughout his career, Klaus Christensen has worked with prominent companies in the pharmaceutical industry, including Hoffmann-La Roche Inc. and F. Hoffmann-La Roche AG. His work has been instrumental in advancing research in neural stem cell technology.
Collaborations
Christensen has collaborated with notable colleagues such as Martin Graf and Roberto Iacone, contributing to the advancement of innovative research in his field.
Conclusion
Klaus Christensen's work in the conversion of somatic cells to neural stem cells represents a significant advancement in regenerative medicine. His contributions continue to influence the scientific community and pave the way for future innovations.